Jeanne Eagels

DIGITALOCEAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DigitalOcean Holdings, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 11, 2023

Investors have until November 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until November 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • According to the complaint, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
  • There is no cost or obligation to you.

JAMES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating James River Group Holdings, Ltd. on Behalf of James River Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 11, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) on behalf of James River stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) on behalf of James River stockholders.
  • Our investigation concerns whether James River has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On November 8, 2023, before market hours, James River announced non-reliance on previously issued financial statements or a related audit report or completed interim review.
  • The Company's management has assessed the effect of the foregoing on the Company's internal control over financial reporting and disclosure controls and procedures.

FREEDOM HOLDING ALERT: Bragar Eagel & Squire, P.C. is Investigating Freedom Holding Corp. on Behalf of Freedom Holding Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 11, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Freedom Holding Corp. (“Freedom Holding” or the “Company”) (NASDAQ: FRHC) on behalf of Freedom Holding stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Freedom Holding Corp. (“Freedom Holding” or the “Company”) (NASDAQ: FRHC) on behalf of Freedom Holding stockholders.
  • Our investigation concerns whether Freedom Holding has violated the federal securities laws and/or engaged in other unlawful business practices.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • On this news, shares of Freedom Holding fell by more than 5.5% in intraday trading on the same day.

INTEGRA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 11, 2023

Investors have until November 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until November 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • In October 2018, the FDA inspected the Boston Facility and found that Integra was in violation of the good manufacturing practice requirements of the Quality System Regulation.
  • Consequently, on November 2, 2018, the FDA issued a Notice of Inspectional Observations on Form 483 (the “2018 Form 483”) to put Integra on notice of those violations.
  • Most significantly, the FDA found that Integra failed to adequately test for bacterial endotoxins in the medical devices manufactured at the Boston Facility.

ENVIVA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enviva Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 11, 2023

Investors have until November 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until November 13, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • The Enviva class action lawsuit further alleges that on May 3, 2023, Enviva revised down its 2023 guidance, lowering its net loss projection from $18-$48 million to $136-$186 million, and suspending dividend payments for 2023.
  • The Enviva class action lawsuit alleges that on this news, the price of Enviva common stock fell more than 67%.

FMC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against FMC Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, November 10, 2023

Investors have until January 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • The Blue Orca Report emphasized that the products at issue, patented diamides (a class of insecticide), “account for almost 40% of FMC’s.
  • In short, Defendants repeatedly falsely reassured investors that FMC had not gone over the patent cliff while, in truth, the Company was already in free fall.
  • On this news, FMC’s stock price fell $8.83 per share, or 12.18%, to close at $58.12 per share on October 23, 2023.

LI-CYCLE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Li-Cycle, Corp. and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, November 10, 2023

Investors have until January 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • On this news, Li-Cycle shares declined by $1.04, or approximately 45.81%, to close at $1.23 per share on October 23, 2023, on unusually heavy trading volume.
  • The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, November 9, 2023

Investors have until January 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • On this news, the Company’s shares fell $1.13, or 34.14%, to close at $2.18 per share on September 25, 2023, on unusually heavy trading volume.
  • The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

PACWEST DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against PacWest Bancorp and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, November 9, 2023

Investors have until November 10, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until November 10, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
  • There is no cost or obligation to you.

NEXTERA ALERT: Bragar Eagel & Squire, P.C. is Investigating NextEra Energy, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, November 9, 2023

Our investigation concerns whether the board of directors of NextEra have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of NextEra have breached their fiduciary duties to the company.
  • According to the Complaint, the Company made false and misleading statements to the market.
  • The Company denied this misconduct despite the fact that the actions of its subsidiary put it at risk of legal and reputational damage.
  • Based on these facts, the Company's public statements were false and materially misleading throughout the class period.